CD69 and neoplasm: Moreover, A2-CAR Jurkat T cells upregulated CD69 and CD25 expression specifically when co-cultured with irradiated HLA-A2+ K562 tumor cells (Supplementary Figure 2C), suggesting that the grafted A2-CAR is able to activate T-cell signaling in response to HLA-A2.